P-glycoprotein restricted transport of nimodipine across blood-brain barrier

Acta Pharmacol Sin. 2003 Sep;24(9):903-6.

Abstract

Aim: To examine whether the transport of nimodipine (NMD) from the circulating blood into the brain is restricted by P-glycoprotein (P-gp) in rat brain capillary endothelial cells (BCEC).

Methods: When cells reached confluence, a time course of NMD uptake was recorded by incubation with a medium containing NMD 10 mg/L at 37 degrees C. Effects of various agents in the steady-state uptake of NMD were tested by co-administration with NMD and each compound to cells at 37 degrees C for 90 min. The uptake of NMD was measured for 90 min. Effects of P-gp inhibitors on the efflux of NMD from primary cultured BCEC were studied by administration of erythromycin, clarithromycin, cyclosporin A (CsA), and Hanks' solution after the accumulation of NMD by BCEC at 37 degrees C for 90 min.

Results: The uptake of NMD by primary cultured rat BCEC was time-dependent, and the steady-state uptake of NMD was increased in the presence of several substrates of P-gp in BCEC. The steady-state uptake was also significantly increased (P<0.01) when cellular ATP was depleted by treatment with sodium azide. Furthermore, efflux of NMD from BCEC was inhibited by erythromycin,clarithromycin, and CsA.

Conclusion: The permeability of NMD into the brain is restricted by P-gp and increased by co-administration with P-gp inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / antagonists & inhibitors
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
  • Animals
  • Blood-Brain Barrier / metabolism*
  • Calcium Channel Blockers / pharmacokinetics*
  • Capillaries
  • Cells, Cultured
  • Cerebral Cortex / blood supply
  • Cyclosporine / pharmacology
  • Drug Resistance, Multiple
  • Endothelium, Vascular / metabolism*
  • Erythromycin / pharmacology
  • Nimodipine / pharmacokinetics*
  • Rats
  • Rats, Nude
  • Rats, Sprague-Dawley

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Calcium Channel Blockers
  • Nimodipine
  • Erythromycin
  • Cyclosporine